SecBot SecBot

GERN

GERON CORP
Nasdaq· Pharmaceutical Preparations· Inc. DE· CIK 0000886744 Biotech & Drug Discovery
$0.9400 −0.03 (−3.09%)
Nov 16 4:00 PM ET · prev $0.9700
Market cap
$640.4M
Small cap
Consensus
Buy
82% Buy or better · 11 analysts
Median target
$3.25
+246% · range $2.50–5.00
1 year
−16.8%
from $1.13 · Nov 17
30 days
−21.7%
from $1.20
52-week range
$0.8900–1.95
−52% from high · low Oct 30
Avg volume 20D
18.61M
Oct 28 spike 81.72M
Short interest
66.95M
≈10.4% of shares · −10.3%
Days to cover
3.9
at average volume
Insider net
🔒 Subscribers only
New fund stakes
0
Q3 2026 13F · 0 exits
Filing reports
9
analyzed by SecBot
SecBot read MIXED 7 reports · 90 days
Balance 1 bearish · 0 bullish · 2 mixed · 4 neutral oldest → newest, height = score
Avg score ·High conf. 6/7

Price

Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).

Signal stack

Where each data set points today.

  • InsidersLOCKED

    1 open-market trade filed or updated in the last 24 hours. 🔒 Subscribers only.

  • InstitutionsBULLISH

    Q3 2026: 23 added (0 new), 11 trimmed or exited.

  • AnalystsBULLISH

    9 of 11 rate it Buy or better. Every target is above the price.

  • Short sellersSTEADY

    Short interest −10.3% to 66.95M shares. 3.9 days to cover, ≈10.4% of shares.

  • TrendDOWNTREND

    20% below its 50-day average.

Who's buying

13F· Q3 2026
0
new positions
0
exits
FundMoveSharesValue
Candriam S.C.A.ADD7,982,968$9.9M
PANAGORA ASSET MANAGEMENT INCADD4,757,473$5.9M
Qube Research & Technologies LtdTRIM2,272,012$2.8M
FRANKLIN TEMPLETON INCDOUBLED1,499,505$1.6M
Squarepoint Ops LLCDOUBLED1,221,587$1.5M
Quadrature Capital LtdADD999,854$1.2M
ALPS ADVISORS INCADD851,184$1.0M
Rafferty Asset Management, LLCADD783,753$964.0K

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

11 analysts
Buy 82% rate it Buy or better
Strong Buy4Buy5Hold2Sell0Strong Sell0
12-month targets · 4 analysts

Price is below the lowest target. Median implies +246%.Targets as of Nov 17, 2026.

Recent actions
DateFirmActionRating
Oct 29, 2026Wedbush
MAINTAIN
MAINTAINOutperform
Oct 28, 2026Needham
MAINTAIN
MAINTAINBuy

Insider ledger

Form 4
🔒 Subscribers only
12 transactions
DateInsiderTypeValue
Nov 16, 2026🔒 Fresh data, subscribers only
Nov 16, 2026
BUY
Sep 30, 2026
Spiegel Robert J.
Director
Sep 30, 2026
AWARD$7.8K
Jun 30, 2026
Spiegel Robert J.
Director
Jun 30, 2026
AWARD$7.8K
May 20, 2026
O'Farrell Elizabeth G.
Director
May 20, 2026
AWARD220,000 sh
May 20, 2026
Molineaux Susan
Director
May 20, 2026
AWARD220,000 sh
May 20, 2026
Spiegel Robert J.
Director
May 20, 2026
AWARD220,000 sh
May 20, 2026
McDonald John F
Director
May 20, 2026
AWARD220,000 sh
May 20, 2026
Bir Dawn Carter
Director
May 20, 2026
AWARD220,000 sh

Earnings setup

Estimates

Revision history: 🔒 Fresh data, subscribers only

PeriodEPS est.Range30D rev.Revenue
Current Q🔒 Fresh data, subscribers only
Next Q$0.01$0.01–$0.01No data$74.5M
Current FY🔒 Fresh data, subscribers only
Next FY$0.09$0.09–$0.09No data$338.1M

Short side

FINRA· Oct 30, 2026
66,951,283
shares short
-10.3%
vs prior settlement
3.9
days to cover
≈10.4%
of shares outstanding
Trading halts
Oct 28, 2026Resumption ScheduledResumed
Recent activity
The latest filings, insider trades, analyst actions, press and options flow, newest first.
Nov 16, 2026 Insider
🔒 Fresh data, subscribers only
Nov 10, 2026 SEC
State Street Corp filed a Schedule 13G disclosing a passive 5.0% stake in Geron Corp as of September 30, 2026, holding…
SC 13G · Impact 3/10
Nov 6, 2026 SEC
Eight institutional investors added $3.6M in GERN positions during Q3 2026, while two trimmed $509K, for net buying of…
INST-CLUSTER · Impact 3/10
Nov 4, 2026 SEC
Geron reported Q3 2026 RYTELO net product revenue of $60.1M, up 27% YoY from $47.2M, and achieved net income of $1.4M…
8-K · Impact 6/10
Nov 4, 2026 Earnings
Geron Corporation Reports Third Quarter 2026 Financial Results and Recent Business Highlights
Achieved $60.1 million in RYTELO ® (imetelstat) net product revenue in Q3 2026, an increase of 5% co
Oct 19, 2026 Press
Geron Corporation granted inducement stock options for 570,000 shares to three new employees at $1.17 per share, a…
Impact 2/10
Sep 30, 2026 Insider
Spiegel Robert J. was granted 6,351 shares
Director @ $1.23 ($7.8K)
Sep 30, 2026 Inst.
Candriam S.C.A. · ADD
7,982,968 shares ($9.9M)
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
1 drug tracked · Drug pipeline →
Recent

SecBot reports

9 filings · 2 press releases · 1 bullish · 1 bearish · 2 mixed · 5 neutral
All GERN filing & press-release reports (11)